People waiting for their first Covid vaccine say they are not put off by blood clot fears – and insist they would still be happy to have AstraZeneca shot. A review by the drugs watchdog the MHRA found that by the end of
Britons were once again left with a raft of questions over the safety of AstraZeneca’s coronavirus vaccine after health chiefs today recommended it should not be given to under-30s because of its link to potentially deadly blood clots. No10’s jab advisory panel
‘Be sensibly British, keep calm, and carry on’: Ex-health secretary Jeremy Hunt urges over-30s to keep getting AZ jab because being ‘over-cautious costs more lives than it saves’ The ex-Cabinet minister backed the MHRA today over the UK-created vaccine Backed regulator who
Britain’s daily Covid cases fall by a third in a week with 2,763 more infections – while deaths rise slightly to 45 Department of Health chiefs said they had identified 2,763 cases and 45 Covid deaths in the past 24 hours More
AstraZeneca share price falls and ends day 1% down after UK regulator said under-30s should not take the jab By James Gant For Mailonline Published: 11:38 EDT, 7 April 2021 | Updated: 11:38 EDT, 7 April 2021 AstraZeneca’s share price has slumped
“Based on the available data and evidence, JCVI has advised that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AstraZeneca vaccine where available,” said Wei Shen Lim, COVID-19 Chair for JCVI.
Under-30s should NOT take the AstraZeneca vaccine, says UK regulator in blow to Britain’s jab roll-out after 79 people suffer brain blood clots out of 20MILLION doses – but officials insist benefits outweigh risks for the vast majority of people By Connor
The European Medicines Agency issued new advice for the Oxford jab after reports of number of people developing blood clots after receiving it. Experts from the bloc’s drugs watchdog said the threat of hospitalisation and death from coronavirus poses a greater risk
Britain’s Covid vaccination drive could slow by at least 75 per cent if AstraZeneca’s jab is banned in people under the age of 50, according to leaked figures which could demolish the Government’s targets for inoculating young people. Vaccine delivery figures from
As a clinical neurologist, I must balance on a daily basis the risks and benefits of interventions in often complex, high-risk situations. While these are specialised decisions about the net benefit of a particular course of action, they are the stuff of